Evaluation of aliphatic acid metabolism in bladder cancer with the goal of guiding therapeutic treatment
Urothelial bladder cancer (BLCA) is a common internal malignancy with a poor prognosis. The re-programming of lipid metabolism is necessary for cancer cell growth, proliferation, angiogenesis and invasion. However, the role of aliphatic acid metabolism genes in bladder cancer patients has not been e...
Main Authors: | Tianbao Song, Kaixiang He, Jinzhuo Ning, Wei Li, Tao Xu, Weimin Yu, Ting Rao, Fan Cheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.930038/full |
Similar Items
-
Biomarkers in Bladder Cancer: Present Status and Perspectives
by: Wun-Jae Kim, et al.
Published: (2007-01-01) -
YRNA expression predicts survival in bladder cancer patients
by: Yuri Tolkach, et al.
Published: (2017-11-01) -
A Novel Prognostic Model Based on Ferroptosis-Related Gene Signature for Bladder Cancer
by: Libo Yang, et al.
Published: (2021-08-01) -
Role of Serum Lymphocyte-derived Biomarkers in Nonmetastatic Muscle-invasive Bladder Cancer Patients Treated with Trimodal Therapy
by: Ronald Kool, et al.
Published: (2022-02-01) -
The Roles of CircRNAs in Bladder Cancer: Biomarkers, Tumorigenesis Drivers, and Therapeutic Targets
by: Fajuan Cheng, et al.
Published: (2021-07-01)